Domov › Velika depresivna motnja › Arkansas › Little Rock

Klinične študije za Velika depresivna motnja v Little Rock, AR

14 študij za Velika depresivna motnja išče udeležence na lokacijah v Little Rock in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Vključevanje udeležencevFaza 3

Preferred Research Partners, Inc., Little Rock

Starost 18–74 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07592689

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Vključevanje udeležencevFaza 3

SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi stran

Starost 18–74 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Vključevanje udeležencevFaza 3

SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi stran

Starost 18–74 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06559306

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Vključevanje udeležencevFaza 3

Vanda Investigational Site, Little Rock

Starost 18–65 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06830044

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Vključevanje udeležencevFaza 4

Neurocrine Clinical Site, Bryant · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07105111

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Vključevanje udeležencevFaza 3

SanRo Clinical Research Group, Bryant · 15 mi stran

Starost 18–74 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Vključevanje udeležencevFaza 2

Draig Clinical Site, Little Rock

Starost 18–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Vključevanje udeležencevFaza 2

Draig Clinical Site, Little Rock

Starost 18–75 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Vključevanje udeležencevFaza 3

Neurocrine Clinical Site, Bryant · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06911112

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Vključevanje udeležencevFaza 3

Woodland International Research Group, Little Rock

Starost 18–74 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Vključevanje udeležencevFaza 3

Neurocrine Clinical Site, Little Rock
Neurocrine Clinical Site, Bryant · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Vključevanje udeležencevFaza 2

Preferred Research Partners /ID# 279206, Little Rock
Woodland International Research Group /ID# 277605, Little Rock

Starost 18–65 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07276997

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Vključevanje udeležencevFaza 2

Pillar Clinical Research, LLC, Little Rock
Preferred Research Partners, Inc., Little Rock

Starost 18–65 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06524830

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Vključevanje udeležencevFaza 3

Neurocrine Clinical Site, Little Rock

Starost 18 in več · Vsi spoli · Posodobljeno 29. okt. 2025 · NCT06786624

Študije za Velika depresivna motnja v drugih mestih

Druge študije v Little Rock

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.